Lilly Asia Ventures
Est. 2008
- HQ
- China
- Founded
- 2008
- Focus
- Generalist Tech
- Tracked deals
- 1
About
Lilly Asia Ventures is a biomedical venture capital firm that originated in 2008 as an Eli Lilly corporate venture subsidiary and later became an independent investment manager.
Strategies
Venture Capital
Focused strategy
Stated investment focus
Firm-wide focus
Healthtech
“The firm invests in innovative medical technologies, including surgical robotics, diagnostics, and digital health platforms.”
Stated focus Source
Life Sciences
“focusing on investments in healthcare and life sciences companies across Asia”
Stated focus Source
Healthcare & Life Sciences
“focusing on investments in healthcare and life sciences companies across Asia”
Stated focus Source
Sources & freshness
Public evidence and reporting dates used for the structured profile. Internal confidence scores are not displayed.
Healthtech · Firm-wide focus
Reviewed secondary source · Observed Oct 9, 2026
Life Sciences · Firm-wide focus
Reviewed secondary source · Observed Oct 9, 2026
Healthcare & Life Sciences · Firm-wide focus
Reviewed secondary source · Observed Oct 9, 2026
Investment Focus
Focus Areas
Stages
Growth pre ipo Public / Listed Seed
Focus
Generalist Tech
Investment Geographies
Primary Markets
China
Coverage
Country-focused Regions
Asia
Coverage is a guide only.
Location
Headquarters
China
Office Presence
No office countries recorded
Deals & Activity
Tracked Deals
1
Most common deal types
Series B (1)
Recent tracked deals
Khartis Therapeutics
Series B - 2026
People also viewed
Sequoia Capital
Sequoia Capital is a venture investment manager that backs companies from inception to IPO and operates venture and dedicated seed funds.
Andreessen Horowitz
Andreessen Horowitz is an investment manager investing in technology companies from seed through growth stage across AI, bio and healthcare, consumer, crypto, enterprise, fintech, games, infrastructure and American dynamism.
New Enterprise Associates
New Enterprise Associates (NEA) is a venture capital firm investing in technology and healthcare across stages, including early-stage and venture-growth opportunities.
Grok Ventures
Grok Ventures is the private investing vehicle of Mike Cannon-Brookes, co-founder of Atlassian and one of Australia's most successful technology entrepreneurs. Grok Ventures invests in fast-growing technology-enabled businesses with world-class management teams who are solving big problems. Grok particularly likes food and energy companies. We have private, patient, long-term capital, with the flexibility to participate from early-stage or seed financing through to late stage funding rounds (although we prefer to be involved earlier).
Bain Capital
Bain Capital is a private investment manager with private equity, growth and venture, credit, and real-assets businesses.
Skip Capital
Skip Capital is a private fund investing in technology and infrastructure, with venture-capital personnel and a separate Essential Infrastructure Fund.